Fertility Choices - Clinical trial • Breast Cancer Foundation NZ

Fertility Choices

Supportive Care clinical trials for ER+

Pending
Updated: January 20, 2022

This study examines the impact of a fertility decision aid developed using health literacy principles on decision-related outcomes in younger women with breast cancer.

This study examines the impact of a fertility decision aid developed using health literacy principles, compared to a gold-standard decision aid, on decision-related outcomes in younger women with breast cancer.

Key inclusion criteria:

  • To be eligible to participate women must:
  • be aged between 18-40 years (inclusive);
  • be pre-menopausal;
  • have a histologically confirmed diagnosis of early-stage breast cancer;
  • have no history of metastatic disease;
  • not have undergone adjuvant therapy for breast cancer;
  • have easy access to the internet;
  • have an interest in finding out more about fertility and/or fertility preservation;
  • be able to give informed consent.

Key exclusion criteria

  • Women who have already started fertility preservation will be excluded.
  • Although women whose primary language is other than English (LOTE) will not explicitly be excluded, women will need to have enough English capability to complete the surveys and communicate with the researchers. Should the oncologist consider the patient’s English skills to be insufficient, they will be excluded.

Full trial information

Australia

ACT, NSW, QLD, SA, WA, VIC

Contact:

Michelle Peate

If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.

Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz

Similar clinical trials

For Supportive Care

Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz

Find clinical trials

Interested in a clinical trial?

Subscribe for updates & stay in the loop with new studies.